RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

BACKGROUND: Criteria for good candidate antigens for immunotherapy of acute myeloid leukemia are high expression on leukemic stem cells in the majority of patients with acute myeloid leukemia and low or no expression in vital tissues. It was shown in vaccination trials that Receptor for Hyaluronic A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Snauwaert, Sylvia, Vanhee, Stijn, Goetgeluk, Glenn, Verstichel, Greet, Van Caeneghem, Yasmine, Velghe, Imke, Philippé, Jan, Berneman, Zwi N., Plum, Jean, Taghon, Tom, Leclercq, Georges, Thielemans, Kris, Kerre, Tessa, Vandekerckhove, Bart
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2012
Assuntos:
Original Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487554/
https://ncbi.nlm.nih.gov/pubmed/22532518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.065581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados